After completing her M.Sci degree in Chemistry at the University of Padova (Italy), Dr Cinzia Imberti moved to the UK to undertake a MRes/PhD at King’s College London, working on the development of radiometal-based radiopharmaceuticals under the supervision of Prof. Phil Blower. In 2018, she was awarded a Sir Henry Wellcome Fellowship to study the mechanism of action of metal-based anticancer agents in the group of Prof. Peter Sadler (University of Warwick). She then joined Dr Jason Lewis’ group at Memorial Sloan Kettering Cancer Centre (New York) as a Research Associate investigating antibody-based imaging agents.

Since 2023, she is working as a Research Scientist in Bayer (Berlin) developing novel metal-based radiotherapies. Cinzia will be returning to King’s College London in May 2024 as UKRI Future Leader Fellow in Imaging Metallomics, where she will be using a unique toolbox of multi-scale imaging techniques to clarify roles and behaviour of metal species – including both essential trace metals and metallodrugs – in cancer.